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Abstract: The marine gastropod Hemifusus tuba is served as a luxury food in Asian countries and used
in traditional Chinese medicine to treat lumbago and deafness. The lack of genomic data on H. tuba is
a barrier to aquaculture development and functional characteristics of potential bioactive molecules
are poorly understood. In the present study, we used high-throughput sequencing technologies to
generate the first transcriptomic database of H. tuba. A total of 41 unique conopeptides were retrieved
from 44 unigenes, containing 6-cysteine frameworks belonging to four superfamilies. Duplication of
mature regions and alternative splicing were also found in some of the conopeptides, and the de novo
assembly identified a total of 76,306 transcripts with an average length of 824.6 nt, of which including
75,620 (99.1%) were annotated. In addition, simple sequence repeats (SSRs) detection identified 14,000
unigenes containing 20,735 SSRs, among which, 23 polymorphic SSRs were screened. Thirteen of
these markers could be amplified in Hemifusus ternatanus and seven in Rapana venosa. This study
provides reports of conopeptide genes in Buccinidae for the first time as well as genomic resources
for further drug development, gene discovery and population resource studies of this species.
Keywords: Hemifusus tuba; transcriptome; conotoxin; simple sequence repeats
1. Introduction
Marine organisms represent half of the total global biodiversity, and as such, they provide
an abundance of chemical space to be explored for peptide-based drug discovery [1]. The toxic
peptides found in marine organisms, such as jellyfish, cone snails, sea urchins and lionfish, are of
great biotechnological interest for applications in medicine. Possible use could be as biochemical tools
in neurophysiological studies and for the discovery of new molecular targets in pharmacology [2].
A diverse range of predatory marine gastropods produce toxins (e.g., Conoidae superfamily), yet most
of these molecules remain unknown or uncharacterised [3].
Hemifusus tuba (Gmelin, 1791), the tuba false fusus, is a marine gastropod of the family
Melongenidae. Its natural range extends from the Sea of Japan through the South China Sea to
the Philippines [4]. H. tuba is served as luxury food in some Asian countries, popular for its delicious
taste and high nutritive value. The economic value of H. tuba has led to increased research efforts
in population genetics [5], conservation [6,7] and aquaculture studies [8,9]. While there is some
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knowledge on the species biology, including the circulatory and respiratory systems [4], reproduction
and behaviour [10–13] and physical characteristics (nutritional composition and microstructure of
the conch shell) [9,14], there is a complete lack of molecular understanding for bioactive compounds
discovery and for the population resource management of this species.
Conotoxins are conopeptides with generally 12−35 amino acids. Initially described in the cone
snail, they have remarkable molecular diversity and have the potential to target neuroreceptors, ion
channels and transporters, with high potency and specificity. They can be bioactive but not specifically
toxic. These attributes make it an attractive candidate for the treatment of neuropathic pain and acute
pain [15]. While Conus species have been in the spotlight of drug discovery, several other marine
gastropod species have been reported to contain bioactive compounds with potential bioactivity, but
most of these compounds have not yet been identified and characterised [3].
Whelks have been used in traditional Chinese medicine for hundreds of years; they were first
mentioned in “Bencao Shiyi”, by Chen Cangqi, around 739 A.D. “Medicinal Fauna of China” [16]
records H. tuba as medicine to treat lumbago and deafness. However, its active ingredients and
molecular mechanisms have not been characterised. The recorded therapeutic effect of H. tuba for pain
relief suggests that it may contain chemical compounds somewhat similar to Conus species.
With the development of high-throughput sequencing platforms, the transcriptome of many
economically important, non-model species of molluscs have been extensively investigated [17],
leading to the discovery of new bioactive compounds, physiological pathways and insights into
the mechanisms of evolution [18–21]. High-throughput sequencing methods have also shown great
potential in screening for polymorphic simple sequence repeats (SSRs or microsatellites) used as
tools for species conservation and sustainable aquaculture production such as studies on population
diversity, conservation genetics, marker-assisted selective breeding and evolutionary analyses [17,22].
The purpose of this study was to develop transcriptomic resources using High-throughput
sequencing to facilitate functional transcript discovery and population genetic study in H. tuba species.
Such new transcriptomic information supports bioactive compound discovery, phylogenetics and
population genetic studies for the exploitation of this commercially important species in the future.
2. Results
2.1. High-Throughput Sequencing and De Novo Assembly
The Illumina sequencing of H. tuba visceral mass tissue generated 33,546,714 raw paired-end reads.
The reads were deposited in the European Bioinformatics Institute (EBI) European Nucleotide Archive
(ENA) project ID PRJEB30840. A total of 22,892,498 paired-end reads (68.2%) passed the pre-processing
filters, and a final 21,397,329 (63.8%) passed the mRNA cleaning step and were used during the de
novo assembly process (Table 1).
The final assembly reconstructed a total of 76,306 transcripts with an average size length of
824.6 nt and an N50 length of 1014.0 nt (Table 1 and Figure 1A). The high-quality (cleaned) reads
were then mapped back to the assembled transcripts to assess the quality of the assembly; as a result,
54.5% of the reads were successfully mapped to the assembled final transcriptome, while 82.9% were
mapped to the raw/unfiltered transcriptome. A Benchmarking Universal Single-Copy Orthologs
(BUSCO) completeness assessment recovered 90.8% of near-universal single-copy orthologs selected
from the Metazoa database (Figure 1B). The clustering of the transcripts generated 61,575 unigenes
(a set of transcripts/isoforms that stem from the same transcription locus, i.e., gene) with a mean length
of 744.2 nt and an N50 length of 865.0 nt (Table 1). The assembly was deposited at the European
Bioinformatics Institute (EBI), analysis ID ERZ976199.
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Table 1. Summary statistics of sequencing and assembly of H. tuba transcriptome.
Category Number/Length
Total number of raw PE reads 33,546,714
Maximum read length (nt) 90
Pre-process PE reads 22,892,498
Cleaned PE reads 21,397,329
Clean bases 1.9 Gb
Transcripts generated (raw) 329,633
Percentage of read assembled 82.9%
Transcripts (filtered) 76,306
Percentage of read assembled 54.5%
GC content 52.9%
Maximum transcripts length 17,498
Minimum transcripts length 300
Transcripts > 500 bp 44,171
Transcripts > 1 kb 17,188
Transcripts > 10 kb 56
N50 length (bp) 1014
Mean length (bp) 824.6
Unigenes 61,575
N50 length (bp) 865 *
Mean length (bp) 744.2 *
* based on the longest transcript for each unigene.
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Figure 1. H. tuba transcript assessments. (A) Length distribution of the assembled H. tuba transcript.
Clean reads for H. tuba were assembled and resulted in 76,306 transcripts. (B) BUSCO assessment
(Metazoa database; number of BUSCO, 978).
2.2. Annotation and Functional Characterisation of the H. tuba Transcriptome
The predicted proteins from the reconstructed transcripts were subjected to BlastP similarity
searches against SwissProt, Pfam, InterPro, Kyoto Encyclopedia of Genes and Genomes (KEGG) and
Gene Ontology (GO) databases. Of the total of 76,306 transcripts, 75,620 (99.1%) were annotated by at
least one database, an 26,388 (34.6%) were annotated in all five databases used (Table 2 a d Figure 2).
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Table 2. Summary of annotation results for H. tuba unigenes using a range of databases.
Database Number annotated
PfamA 60,116
InterPro * 38,711
SwissProt 41,468
KEGG 64,235
GO 42,819
All 26,388
Total 75,620
* InterPro covers 12 databases (CATH-Gene3D, CDD, HAMAP, PANTHER, PIRSF, PRINTS, ProDom, PROSITE
(patterns and profiles), SFLD, SMART, SUPERFAMILY, TIGRFAMs).
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and ATP binding (1119 transcripts) were the most abundant groups. 
Figure 2. A five-way Venn diagram. The figure shows the unique and overlapped transcripts showing
predicted protein sequence similarity with one or more databases (details in Table 2).
A total of 42,819 assembled transcripts were allocated into three major GO classes: 11,570
(27.02%) transcripts were allocated into “biological processes”; 10,268 transcripts (23.98%) into “cellular
components”; and 20,981 (49.00%) into “molecular functions” (Figure 3). In the biological process
category, the oxidation–reduction process (432 transcripts), protein phosphorylation (287 transcripts)
and signal transduction (281 transcripts) were the most abundant groups. In cellular component
terms, the integral component of membrane (1583 transcripts), membrane (903 transcripts), cytoplasm
(752 transcripts) and nucleus (743 transcripts) were the dominant groups. Under the molecular function
category, protein binding (4915 transcripts), nucleic acid binding (1656 transcripts) and ATP binding
(1119 transcripts) were the most abundant groups.
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Figure 3. Level 2 GO annotations using the gene ontology (GO) of assembled transcripts.
2.3. Conopeptide Identification
Literature reported the conotoxin protein/transcript/gene as a “precursor”, while the mature toxin
peptide region is referred as a “c nopeptide”. This leads to confusion when one precursor contains
more than one toxin peptide region/conopeptide domain. For clarity, we are using “con toxin protein”
and “conopeptide”.
In order t capture the diversity of conotoxin, the predicted protein translation of all transcripts
was used to c nduct an initial BlastP search against the known conopeptide sequences. A total of
66 transcripts were identified as coding for putative conotoxin pr teins (Supplementary Table S1).
A total of 82 conopeptide domains (toxin peptide regio ; Supplementary Table S2) were extracted from
the initial search. Following further classification using a conservative BlastP (e-value threshold <
10−10) and both ConoSorter and ConoDictor analysis, a total of 58 transcripts (from 45 unigenes) were
categorise as coding conotoxi proteins and 73 conopeptide domains were clustered (Figure 4A).
As these peptides were small and very polymorphic, the gene tree generated was of low
discrimination. After removing these identical/high similarity sequences, 41 unique conopeptides
were retrieved as described below:
1) The structure of ost conotoxin proteins identified in this study generally consists of three
distinct regions: a N-terminal signal peptide region, a less-conserved intervening pro-peptide region
(pro-region), and a hypervariable C-terminal mature toxin region (conopeptide). Of the 58 distinct
conotoxin transcripts identified, 31 contain the complete coding sequences (CDS) including the
signal-pro-mature toxin canonical structure and 27 were partial and incomplete (Figure 4B).
2) Of the 41 unique conopeptides, 40 were disulphide-rich conopeptides, which contained two or
more disulphides, and a total of six patterns of Cys frameworks, the most abundant one being the type
“IX” with 6-Cys residues arranged in the pattern “C-C-C-C-C-C” (Table 3).
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classified. The Cys fra e ork is reported on the outer section of the tree. Every conopeptide in
a multi-domain protein was included in the analysis. Domains aligned with respective domain of
duplicated genes. (B) Structure of conotoxin proteins. Types 1, 2 and 3 were complete transcripts, while
4 to 11 were truncated transcripts or incompletely characterised proteins.
Table 3. Summary of the cysteine framework distribution for the conopeptide and unique conopeptide
sequences (details in Supplementary Table S2).
Cysteine Framework Conopeptide Unique Conopeptide
Unclassified 9 5
NoCys 2 1
I or XXIV 1 1
VIII 7 5
XIV 3 1
XXII 3 1
IX 48 27
3) According to the BlastP results of the signal peptide region, four super-families homologous
to the peptide of Conus species are reported (O1, O4, Divergent MTFLLLLVSV, and Divergent
MKVAVVLLVS), where the most abundant one was the “Divergent MTFLLLLVSV”.
4) Eleven conotoxin proteins contained multiple conopeptides (up to three; Figure 4B). There
were four proteins encoding three conopeptides and seven encoding two conopeptides. The multiple
conopeptides, from the same protein, were different from each other.
5) The conopeptide domains of multiple-domain proteins were more similar between proteins than
between domains. This suggests old domain duplications, followed by more recent gene duplications.
Gene duplication was detected in nine of the 58 distinct conotoxin protein sequences.
6) To investigate the relative transcription levels of different conotoxin proteins, we report the
abundance of each conotoxin transcript (expressed in number of fragments per kilobase of transcript
per million mapped fragments, FPKM; Supplementary Table S1).
2.4. Characterisation and Validation of Microsatellites
A total of 20,735 SSR loci were detected in 14,000 (22.7%) sequences out of 61,575 unigenes,
including 6975 di-nucleotide, 11,654 tri-nucleotide, 1812 tetra-nucleotide, 278 penta-nucleotide and
16 hexa-nucleotide type repeats (Table 4). The frequencies of AC/GT and AG/CT were highest in
di-nucleotide repeats, accounting for 61.1% and 35.3% of di-nucleotide SSRs, respectively. AT and
TA repeats accounted for 1.6% and 0.9% of di-nucleotide SSRs respectively. Within the tri-nucleotide
repeats, AGC/CTG (22.6%), followed by ACC/GGT (21.7%) were the most repeated motifs.
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Table 4. Distribution of the perfect SSR motifs in the H. tuba transcriptome.
SSR Type SSR Number Unigenes Number Occurrence (%) Total (%)
Di-nucleotide 6957 5167 11.3 33.6
Tri-nucleotide 11,654 8418 19.0 56.2
Tetra-nucleotide 1812 1358 3.0 8.7
Penta-nucleotide 278 232 0.5 1.3
Hexa-nucleotide 16 15 <0.1% 0.1
Total 20,735 14,000 33.7 100.0
Fifty-eight microsatellite-containing sequences were selected for microsatellite marker optimisation
and validation because of their repetition times and flaking sequence priority. Of the 58 primer
pairs, 22 were not amplified, 13 produced monomorphic profiles and 23 were polymorphic among
30 individuals of H. tuba. The characteristics of these polymorphic loci are shown in Supplementary
Table S3. The number of alleles ranged from 2 to 9. The observed and expected heterozygosity
ranged from 0.23 to 1.00 and 0.24 to 0.87 with an average of 0.85 and 0.68, respectively. The ranges of
polymorphic information content (PIC) were from 0.22 to 0.84. Nine of the 23 loci showed significant
departure from the Hardy–Weinberg equilibrium after a sequential Bonferroni correction and no
significant pairwise linkage disequilibrium between any loci (p-value < 0.001).
All 23 polymorphic SSR loci were subsequently used in cross-species amplification tests in two
other related species. Thirteen of the 23 markers could be transferred to H. ternatanus and 7 could be
amplified in R. venosa (Table 5).
Table 5. Characterisation of successful cross-species amplification of microsatellite loci in two different
whelk species, H. ternatanus (n = 16) and R. venosa (n = 20). * loci present in the three species.
Species Locus Size Range (bp) NA HO HE
H. ternatanus
HT4 211-219 4 1.000 0.736
HT10 209-218 4 1.000 0.690
HT20 179-189 6 1.000 0.762
HT22 138-148 6 1.000 0.782
HT24 212-216 3 0.250 0.232
HT25 * 168-180 7 1.000 0.867
HT27 123-137 2 0.563 0.466
HT28 * 122-128 4 1.000 0.651
HT29 132-152 10 1.000 0.891
HT32 249-259 5 0.875 0.718
HT35 155-159 3 0.688 0.599
HT36 * 249-261 6 1.000 0.835
HT39 141-147 4 1.000 0.736
R. venosa
HT15 126-136 6 1.000 0.794
HT23 254-262 5 0.950 0.676
HT25 * 168-182 8 1.000 0.876
HT28 * 120-124 3 1.000 0.559
HT31 117-125 5 1.000 0.788
HT36 * 245-251 4 1.000 0.740
HT37 280-290 6 1.000 0.781
NA, observed number of alleles; HO, observed heterozygosity; HE, expected heterozygosity.
3. Discussion
H. tuba is a valuable species for food and potential marine resources discovery; however, bioactive
compound exploitation and fisheries’ management are hindered by the lack of genomic resources
available. This study presents the first transcriptome analysis of the marine whelk H. tuba. Key findings
include the identification of conopeptides from a member of the Buccinidae family, which may lead to
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new bioactive compounds and a number of microsatellite markers that can be used for population
genetic studies and resource management programmes.
The average length of the unigenes obtained (744.2 nt) was comparable to recently published
transcriptomes in other gastropod species such as R. venosa (619.0 nt; [23]), Pomacea maculata (878.0 nt; [24]),
Koreanohadra kurodana (678 nt; [25]) and Clithon retropictus (736.9 nt; [22]). The transcriptome completeness
of H. tuba was assessed using BUSCO and showed 90.8% of ortholog genes present, which confirmed the
good coverage of the total gene content of this species and the overall robustness of the transcriptome
sequencing, assembly and annotation pipeline.
Peptide therapeutics is a promising research area for new drug discovery in the pharmaceutical
industry. It is attracting increasing interest due to peptide’s high potency, bioavailability, reduced
toxicity, drug to drug cross-reactions, and tissue accumulation [26].
Conotoxins are translated from mRNA, and transcriptome sequencing is now the main method
for the identification of new conotoxins [27]. Recent studies on the venom duct transcriptome of
several Conus species have uncovered about 100 conopeptide genes per Conus species [28]. In this
study, a total of 58 transcripts coding for 73 conopeptides were identified from the transcriptome of
H. tuba. This is the first report of conopeptide genes in the Buccinidae family, which lay the foundation
for further research on characterisation of active compounds for the biological, biotechnological and
medical aspect of this species.
Conotoxins are generally classified based on one of three criteria: 1) “gene superfamily”,
a classification scheme defined by a highly conserved signal sequence in the protein and evolutionary
relationships between conopeptides; 2) “cysteine framework”, a scheme based on the arrangement
of cysteines; or 3) “pharmacological family”, this scheme reflects the target specificity of each
conopeptide [15].
By definition, conotoxins within a superfamily share a similar signal peptide sequence, but with
remarkable structural and functional diversity in the encoded mature peptides [27]. In our study,
according to the BlastP results of the signal peptide region, four superfamilies with a strong homology
to Conus species are reported, the most abundant one being the “Divergent MTFLLLLVSV”. It should
be pointed out that, although most of the signal peptide regions were grouped into “Divergent
MTFLLLLVSV”, their sequences were distinct from each other, indicating that they may belong to
several distinct superfamilies. In addition, conotoxins typically contain a single copy of the mature
peptide encoded near the C-terminus [27]. However, several conotoxins found in H. tuba exhibit
multiple conopeptides (up to three, Figure 4B). The same structure was reported in the disulphide-poor
conoCAP (a short peptide with a single disulphide) and numerous other pre-pro-hormone precursor,
such as FMRF-amides (H-Phe-Met-Arg-Phe-NH2) and enkephalins [27]. The sequence diversity found
in H. tuba conotoxins may be caused by the genetic divergence to the classical Conus species groups,
but it could also reflect the existence of a unique superfamily of uncharacterised function (e.g., venom
for hunting strategies or as a defensive strategy [29]).
Conotoxins are classified into gene superfamilies by their conserved signal sequence, which
is usually associated with a characteristic cysteine framework. Each cysteine framework is in turn
associated with a different pharmacological activity [30]. In our study, a total of six patterns of
cysteine frameworks were identified, the most abundant one was the type “IX” with six cysteine
residues arranged in the pattern “C-C-C-C-C-C”. Although the molecular target of any framework
IX conopeptide has not been identified yet, classification research suggests that these peptides are
specific to mollusc (some clades of cone snails) and worm-hunting species (turrid and terebrid snails,
and some clades of cone snails), but are not produced by fish-hunting cone snail species [31]. H. tuba
under laboratory conditions appears to be a highly specialised predator feeding on bivalves using
different strategies depending on the prey items (e.g., shallow-burrowing or epibyssate species) [10].
The abundancy of the type “IX” cysteine framework of H. tuba may be related to the predatory strategies,
biotic interactions and evolutionary history of this species.
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The number of disulphide bonds is also one of the important characteristics of conopeptides [26].
It is worth noting that of the 41 unique conopeptides found in H. tuba, most (40) were disulphide-rich
conopeptides, which contained two or more disulphides; only one disulphide-poor conopressin was
identified, where this vasopressin-like peptide may be a good candidate for novel antagonist design
because it may act as a selective antagonist to the human V1a receptors [32].
The venom of the Conidae family comprises a complex mixture of hundreds to thousands of
conopeptides that are delivered from the venom apparatus for prey capture and self-defence [3].
Surprisingly, in this study, a lot of conotoxin homologs were identified from H. tuba, Buccinidae
family, which stimulated several interesting questions, for example: What is the evolutionary origin
of conopeptide genes? What could be the implications of these genes for H. tuba? Does H. tuba have
the capacity to employ venom in its hunting strategies? If not, what are the potential functions of the
conopeptides in H. tuba (i.e., are they a defensive strategy)? Also, if they are not venomous in nature,
does the discovery of conotoxins in a Buccinidae family member force us to reconsider the current
definition of conotoxins? Further investigations are required to understand the underlying molecular
mechanisms behind conopeptide origin, functions and structure and predict their targets to ultimately
design potential novel conopeptides with specific biotechnological applications [33].
The assembled and annotated transcriptome is a valuable resource for the large-scale discovery of
putative functional transcripts and SSR markers for the species [17,22]. In our study, the predicted
proteins from the reconstructed transcripts were subjected to BlastP similarity searches against the
SwissProt, Pfam, InterPro, KEGG and GO databases. Of the total of 76,306 transcripts, 75,620 (99.1%)
were annotated by at least one database, 26,388 (34.6%) were annotated in all five databases, and
a total of 42,819 assembled transcripts were allocated into three major GO classes, which provided
important candidates for the research of the different functional genes of H. tuba. Furthermore, the
identification and analysis of SSR markers in the transcriptome will be useful for population genetics
to assess the diversity of the resources and help marker-assisted selective breeding, which will have a
more immediate impact on species conservation and aquaculture production. In the present study,
a total of 20,735 SSR loci were detected in 14,000 unigenes, accounting for approximately 22.7%
of the total unigenes. The frequency of transcriptome-derived SSRs in H. tuba was higher than in
other species of marine mollusc such as Paphia undulata (7.5%) [34], Clithon retropictus (17.4%) [22]
and Crassadoma gigantea (19.98%) [35]. Among the potential SSRs, the most abundant type was
tri-nucleotide repeats, which was also reported in the Zhikong Scallop (Chlamys farreri) and Yesso
Scallop (Patinopecten yessoensis) [36].
Of the 58 primer pairs designed for microsatellite validation, 23 were polymorphic among
30 individuals of H. tuba; this success rate (39.7%) was comparable to previously published
transcriptome-derived SSRs in molluscs [35]. The SSRs identified in this study can be valuable
for the quantification of genetic diversity within and among wild populations of H. tuba and for genetic
improvement programs (such as the construction of a genetic linkage map and Quantitative Trait Locus
Analysis). SSR markers derived from transcribed regions of DNA are expected to be more conserved
and have a higher rate of cross-species applications than genomic SSR markers [37].
In our study, the majority of SSR loci from H. tuba revealed cross-species amplification in two
other marine gastropods. Thirteen of the 23 markers could be amplified in H. ternatanus and 7 in
R. venosa; the relatively lower cross-species amplification in R. venosa, reflect the evolutionary distant
with H. tuba. Since only one population of each species was used to amplify the microsatellite markers,
the polymorphism of these microsatellites might be underestimated. Overall, the SSRs identified in
this study will support the study of population resources.
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4. Materials and Methods
4.1. Sample Collection
The visceral mass tissue of an adult female of H. tuba collected from Wenzhou, Zhejiang Province,
was carefully dissected and immediately placed in liquid nitrogen for RNA preparation. Another 30
wild individuals were sampled from Wenzhou, Zhejiang Province, for SSR polymorphism validation.
Furthermore, 16 wild individuals of Hemifusus ternatanus collected from Wenzhou, Zhejiang Province,
and 20 wild individuals of Rapana venosa collected from Qingdao, Shandong Province, were used to
test the cross-species amplification. The muscles of these samples were preserved in 100% ethanol
until DNA extraction.
4.2. RNA Isolation
The frozen tissues were ground into a fine powder in liquid nitrogen and total RNA was
isolated using TRIzol reagent (Invitrogen, Waltham, MA, USA) and extracted in accordance with the
manufacturer’s protocol. The extracted RNA was treated with RNase-free DNase I (Qiagen, Venlo,
Netherlands) to remove the genomic DNA. The purity and concentration of RNA were measured
using a NanoDrop-2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and Agilent
Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). Approximately 5 µg of RNA
was used as the input material for cDNA library construction.
4.3. Library Construction and Sequencing
The construction and sequencing of the cDNA library were done by Beijing Genomics Institute
(BGI, Beijing, China). Briefly, the poly (A) messenger RNA was isolated from the total RNA samples with
oligo (dT) attached magnetic beads (Illumina, San Diego, CA, USA) and the mRNA was fragmented into
short fragments using divalent cations under elevated temperature. The cleaved RNA fragments were
reverse-transcribed to the first-strand cDNAs by random hexamer primers. Then, the second-strand
cDNAs were synthesised to construct the final cDNA library (Illumina, San Diego, CA, USA). After the
end repair processing and ligation of the adaptor, RNA was amplified using PCR and purified using
QIAquick Gel extraction Kit (Qiagen, Venlo, Netherlands). The cDNA library of visceral mass tissue
was sequenced on Illumina Hiseq 2000 platform (Illumina, San Diego, CA, USA) with paired-end reads
of 90 nucleotides.
4.4. Quality Control and De Novo Assembly
Reads of low quality (i.e., with an average quality score less than 20), having ambiguous bases,
being too short, or PCR duplicates were discarded using PrintSeq v0.20.4 [38], and adaptors were
clipped using Trimmomatics v0.38 [39]. Ribosomal RNA was further removed using SortMeRNA
v3.0.2 [40] against the Silva version 119 rRNA databases [41]. The remaining reads were assembled using
Trinity v2.8.4 [42]. The raw assembly was filtered for a minimum transcript length of 300 nucleotides
and a detectible CDS with TransDecoder v5.5.0 (https://transdecoder.github.io/). The longest CDS of
all the similar alternative splice-form (transcripts) sets was selected as a unigene. Completeness of the
assembly was assessed using BUSCO v3 [43] with the Metazoa dataset.
4.5. Annotation and Functional Classification
The resulting de novo transcriptome was annotated using InterProscan v5.33-72.0 [44,45],
Swiss-Prot release 2018_11 [46] and Pfam release 32.0 database [47]. For classification, the transcripts
were handled as queries using Blast+/BlastP v2.8.1 [48], e-value threshold of 10−5, against Kyoto
Encyclopedia of Genes and Genomes (KEGG) release 89.0 [49]. Gene Ontology [50] were recovered
from InterPro, KEGG and SwissProt annotations. Subsequently, classification was performed using R
v3.5.1 [51].
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4.6. Conotoxin Identification and Classification
Conopeptides datasets from both ConoServer [52] (6275 peptide sequences, accessed 2019 May
1st http://www.conoserver.org/) and ConoDB (7407 peptide sequences, updated 2018 January 1st;
http://conco.ebc.ee) were downloaded and merged. A BlastP v2.8.1 [48] search was conducted using
this Conopeptides database (relaxed e-value threshold < 10−5) and the protein translation of H. tuba
transcriptome in order to capture the diversity of the conotoxin protein. The putative conopeptide
domains were extracted based on the initial BlastP alignment (more than one conopeptide domains
been allowed per protein). Each conopeptide was further analysed and kept only if passing a stricter
BlastP (e-value threshold < 10−10), ConoSorter [53] v1.1 or ConoDictor [54]. All conopeptides that
passed the filter were aligned using Clustal Omega v1.2.4 [55]. An unrooted phylogenetic tree was
inferred using RAxML v8.2.12 [56] under a GTR + I + Γ model of sequence evolution with 10,000
bootstrap replicates. The cysteine (Cys) framework was assigned manually based on Kass et al. [52].
To provide names for conotoxin proteins/genes identified in this study, we used the following naming
conventions: two letters to denote the species, the cysteine framework number (or gene superfamily
name, when available), and a number denoting the order of discovery within the gene superfamily for
that species. Conopeptides followed the same convention, but a lowercase letter was added in the case
of multiple domains.
4.7. Microsatellite Detection and Validation
To detect perfect simple sequence repeats (SSRs), MISA v1.0 was used (http://pgrc.ipk-gatersleben.
de/misa/). SSR loci were identified using the search criteria with the minimum repetitions of di-, tri-,
tetra-, penta-, and hexanucleotides being 6, 5, 5, 5, and 5, respectively, and the flanking sequence length
of the SSR loci was greater than 100 bp. For SSR validation of polymorphism, primers were designed
using the Primer 3 v2.40 [57].
Genomic DNA was isolated from muscles by using the traditional proteinase-K digestion and
phenol-chloroform extraction method. The reaction mixture contained 5 µL 2× Power Taq PCR Master
Mix (BioTeke, Beijing, China), 100 ng template DNA and 1 µM each primer set in a total volume of
10 µL. PCR amplification was performed with the following program: 5 min at 94 ◦C; 36 cycles of
1 min at 94 ◦C, annealing (see Supplementary Table S3 for annealing temperatures) for 1 min, 72 ◦C
for 1 min per cycle and followed by 5 min at 72 ◦C. The amplified products were separated on 8%
denaturing polyacrylamide gel at 1000 V for 4 h and visualised using silver staining. Allele sizes were
characterised by using a 10-bp DNA ladder (Invitrogen, Waltham, MA, USA).
The number of alleles, the observed and expected heterozygosity and polymorphism information
content (PIC) were calculated by using CERVUS v3.0.3 [58]. Deviations from the Hardy–Weinberg
equilibrium (HWE) and linkage disequilibrium (LD) were tested using GENEPOP v4.2 [59]. Sequential
Bonferroni corrections [60] were applied for all multiple tests (p-value < 0.001).
5. Conclusions
This study presents the first assembled and annotated reference transcriptome in H. tuba. Multiple
conotoxin transcripts were identified and their analysed structure provided potential new sources of
bioactive compounds for the pharmaceutical sector. In addition, microsatellite markers were identified
and validated in H. tuba as well as two other related species (H. ternatanus and R. venosa). Overall, this
study provides the genomic resources and newly discovered conotoxin in H. tuba for t future drug
development and population resource studies of this species.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/8/466/s1,
Supplementary Table S1: Sequence and structure of the 66 putative conotoxin proteins. Supplementary Table S2:
Details of the 82 containing putative conopeptides domains and following characterisation. Supplementary Table
S3: Characterisation of 23 polymorphic microsatellite loci in H. tuba.
Mar. Drugs 2019, 17, 466 12 of 15
Author Contributions: Conceptualization, R.L., C.W. and C.M.; methodology, R.L. and M.B.; formal analysis,
M.B., R.L. and H.M.; investigation, L.W., C.M. and W.S.; writing—original draft preparation, R.L. and M.B.;
writing—review and editing; funding acquisition, R.L., C.W. and H.M.
Funding: This research was funded by the National Natural Science Foundation of China (No. 41206113),
Scientific and Technical Supporting Program (2011BAD13B0903), Educational Commission of Zhejiang Province
(Y201224623), Natural Science Foundation of Ningbo (2012A610139), CSC Scholarship (201708330421) and K.C.
Wong Magana Fund in Ningbo University.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Sable, R.; Parajuli, P.; Jois, S. Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of
Natural Sources for Pharmaceutical Applications. Mar. Drugs 2017, 15, 124. [CrossRef] [PubMed]
2. Stonik, V.A.; Stonik, I.V. Toxins Produced by Marine Invertebrate and Vertebrate Animals: A Short Review;
Gopalakrishnakone, P., Ed.; Springer: Dordrecht, The Netherlands, 2014.
3. Turner, A.H.; Craik, D.J.; Kaas, Q.; Schroeder, C.I. Bioactive Compounds Isolated from Neglected Predatory
Marine Gastropods. Mar. Drugs 2018, 16, 118. [CrossRef] [PubMed]
4. Depledge, M.; Phillips, D. Circulation, respiration and fluid dynamics in the gastropod mollusc, Hemifusus tuba
(Gmelin). J. Exp. Mar. Biol. Ecol. 1986, 95, 1–13. [CrossRef]
5. Pan, Y.; Mu, C.; Li, Q.; Su, X.; Ou, X.; He, J.; Wu, X.; Chen, D. AFLP analysis revealed differences in genetic
diversity of Hemifusus tuba. Period. Ocean Univ. China 2013, 43, 58–62.
6. Yuan, Y.; Li, Q.; Pan, Y.; Kong, L.-F. Isolation and characterization of microsatellite loci in the tuba false fusus
(Hemifusus tuba Gmelin). Conserv. Genet. Resour. 2009, 1, 9–11. [CrossRef]
7. Wu, L.; Li, R.; Wang, C.; Mu, C.; Song, W. Isolation and characterization of 42 microsatellite loci from the
Hemifusus tuba Gmelin. Conserv. Genet. Resour. 2014, 6, 707–710. [CrossRef]
8. Ruan, P.; Jiang, X.; Peng, R.; Li, S. Technique probe: Artificial hatching for seawater snail Hemifusus tuba at
industrialized scale. J. Ningbo Univ. 2015, 28, 11–15.
9. Zhou, S.; Jiang, M.; Jiang, X.; Du, X.; Peng, R.; Han, Q. Effects of dietary betaine on feeding, growth
performance, tissue nutritional components and digestive enzyme activities of Hemifusus tuba Gmelin. Chin. J.
Anim. Nutr. 2018, 30, 3319–3328.
10. Morton, B. Prey preference, capture and ration in hemifusus tuba (Gmelin) (prosobranchia: Melongenidae).
J. Exp. Mar. Biol. Ecol. 1985, 94, 191–210. [CrossRef]
11. Morton, B. Reproduction, juvenile growth, consumption and the effects of starvation upon the South China
Sea whelk Hemifusus tuba (Gmelin) (Prosobranchia: Melongenidae). J. Exp. Mar. Biol. Ecol. 1986, 102, 257–280.
[CrossRef]
12. Mortem, B. Juvenile growth of the South China Sea whelk Hemifusus tuba (Gmelin) (Prosobranchia:
Melongenidae) and the importance of sibling cannibalism in estimates of consumption. J. Exp. Mar. Biol. Ecol.
1987, 109, 1–14. [CrossRef]
13. Yang, Z.; Li, R.; Mu, C.; Song, W.; Wang, C. Cytological observation of fertilization and analyse of the nurse
eggs in Hemifusus tuba (Gmelin). J. Fish. China 2016, 40, 1674–1682. [CrossRef]
14. Liang, Y.; Zhao, J.; Wu, C. The micro/nanostructure characteristics and the mechanical properties of Hemifusus
tuba conch shell. J. Bionic Eng. 2010, 7, 307–313. [CrossRef]
15. Kaas, Q.; Westermann, J.-C.; Craik, D.J. Conopeptide characterization and classifications: An analysis using
ConoServer. Toxicon 2010, 55, 1491–1509. [CrossRef] [PubMed]
16. Medicinal Fauna of China Group. Medicinal Fauna of China; Tianjin Science and Technology Publishing
House: Tianjin, China, 1983.
17. Patnaik, B.B.; Wang, T.H.; Kang, S.W.; Hwang, H.-J.; Park, S.Y.; Park, E.B.; Chung, J.M.; Song, D.K.; Kim, C.;
Kim, S.; et al. Sequencing, De Novo Assembly, and Annotation of the Transcriptome of the Endangered
Freshwater Pearl Bivalve, Cristaria plicata, Provides Novel Insights into Functional Genes and Marker
Discovery. PLoS ONE 2016, 11, e0148622. [CrossRef]
18. De Oliveira, A.L.; Wollesen, T.; Kristof, A.; Scherholz, M.; Redl, E.; Todt, C.; Bleidorn, C.; Wanninger, A.
Comparative transcriptomics enlarges the toolkit of known developmental genes in mollusks. BMC Genom.
2016, 17, 905. [CrossRef] [PubMed]
Mar. Drugs 2019, 17, 466 13 of 15
19. Harney, E.; Dubief, B.; Boudry, P.; Basuyaux, O.; Schilhabel, M.B.; Huchette, S.; Paillard, C.; Nunes, F.L.
De novo assembly and annotation of the European abalone Haliotis tuberculata transcriptome. Mar. Genom.
2016, 28, 11–16. [CrossRef]
20. Verdes, A.; Anand, P.; Gorson, J.; Jannetti, S.; Kelly, P.; Leﬄer, A.; Simpson, D.; Ramrattan, G.; Holford, M.
From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics
from Terebridae Peptide Toxins. Toxins 2016, 8, 117. [CrossRef]
21. Yao, G.; Peng, C.; Zhu, Y.; Fan, C.; Jiang, H.; Chen, J.; Cao, Y.; Shi, Q. High-Throughput Identification
and Analysis of Novel Conotoxins from Three Vermivorous Cone Snails by Transcriptome Sequencing.
Mar. Drugs 2019, 17, 193. [CrossRef]
22. Park, S.; Patnaik, B.; Kang, S.; Hwang, H.-J.; Chung, J.; Song, D.; Sang, M.; Patnaik, H.; Lee, J.; Noh, M.; et al.
Transcriptomic analysis of the endangered Neritid species Clithon retropictus: De novo assembly, functional
annotation, and marker discovery. Genes 2016, 7, 35. [CrossRef]
23. Song, H.; Yu, Z.-L.; Sun, L.-N.; Gao, Y.; Zhang, T.; Wang, H.-Y. De novo transcriptome sequencing and
analysis of Rapana venosa from six different developmental stages using Hi-seq 2500. Comp. Biochem. Physiol.
Part D Genom. Proteom. 2016, 17, 48–57. [CrossRef] [PubMed]
24. Mu, H.; Sun, J.; Heras, H.; Chu, K.H.; Qiu, J.-W. An integrated proteomic and transcriptomic analysis
of perivitelline fluid proteins in a freshwater gastropod laying aerial eggs. J. Proteom. 2017, 155, 22–30.
[CrossRef] [PubMed]
25. Kang, S.W.; Patnaik, B.B.; Hwang, H.-J.; Park, S.Y.; Chung, J.M.; Song, D.K.; Han, Y.S.; Patnaik, H.H.;
Lee, J.B.; Kim, C.; et al. Transcriptome sequencing and de novo characterization of Korean endemic land
snail, Koreanohadra kurodana for functional transcripts and SSR markers. Mol. Genet. Genom. 2016, 291,
1999–2014. [CrossRef] [PubMed]
26. Akondi, K.B.; Muttenthaler, M.; Dutertre, S.; Kaas, Q.; Craik, D.; Lewis, R.J.; Alewood, P.F. Discovery,
Synthesis, and Structure–Activity Relationships of Conotoxins. Chem. Rev. 2014, 114, 5815–5847. [CrossRef]
[PubMed]
27. Robinson, S.D.; Norton, R.S. Conotoxin Gene Superfamilies. Mar. Drugs 2014, 12, 6058–6101. [CrossRef]
28. Peng, C.; Yao, G.; Gao, B.-M.; Fan, C.-X.; Bian, C.; Wang, J.; Cao, Y.; Wen, B.; Zhu, Y.; Ruan, Z.; et al.
High-throughput identification of novel conotoxins from the Chinese tubular cone snail (Conus betulinus)
by multi-transcriptome sequencing. GigaScience 2016, 5, 17. [CrossRef]
29. Dutertre, S.; Jin, A.-H.; Vetter, I.; Hamilton, B.; Sunagar, K.; Lavergne, V.; Dutertre, V.; Fry, B.G.; Antunes, A.;
Venter, D.J.; et al. Evolution of separate predation- and defence-evoked venoms in carnivorous cone snails.
Nat. Commun. 2014, 5, 3521. [CrossRef]
30. Gorson, J.; Ramrattan, G.; Verdes, A.; Wright, E.M.; Kantor, Y.; Srinivasan, R.R.; Musunuri, R.; Packer, D.;
Albano, G.; Qiu, W.-G.; et al. Molecular Diversity and Gene Evolution of the Venom Arsenal of Terebridae
Predatory Marine Snails. Genome Biol. Evol. 2015, 7, 1761–1778. [CrossRef]
31. Aguilar, M.B.; de la Rosa, R.A.C.; Falcón, A.; Olivera, B.M.; Heimer de la Cotera, E.P. Peptide pal9a from
the venom of the turrid snail Polystira albida from the Gulf of Mexico: Purification, characterization, and
comparison with P-conotoxin-like (framework IX) conoidean peptides. Peptides 2009, 30, 467–476. [CrossRef]
32. Dutertre, S.; Croker, D.; Daly, N.L.; Andersson, Å.; Muttenthaler, M.; Lumsden, N.G.; Craik, D.J.; Alewood, P.F.;
Guillon, G.; Lewis, R.J. Conopressin-T fromConus tulipaReveals an Antagonist Switch in Vasopressin-like
Peptides. J. Biol. Chem. 2008, 283, 7100–7108. [CrossRef]
33. Mansbach, R.A.; Travers, T.; McMahon, B.H.; Fair, J.M.; Gnanakaran, S. Snails in Silico: A Review of
Computational Studies on the Conopeptides. Mar. Drugs 2019, 17, 145. [CrossRef] [PubMed]
34. Wu, X.; Liu, X.; Yu, Z. Analysis of novel immune–related genes and microsatellite markers in the transcriptome
of Paphia undulata. J. Oceanol. Limnol. 2019, 37, 1301–1316. [CrossRef]
35. Cao, S.; Zhu, L.; Nie, H.; Yin, M.; Liu, G.; Yan, X. De novo assembly, gene annotation, and marker development
using Illumina paired-end transcriptome sequencing in the Crassadoma gigantea. Gene 2018, 658, 54–62.
[CrossRef] [PubMed]
36. Wang, S.; Hou, R.; Bao, Z.; Du, H.; He, Y.; Su, H.; Zhang, Y.; Fu, X.; Jiao, W.; Li, Y.; et al. Transcriptome
sequencing of Zhikong scallop (Chlamys farreri) and comparative transcriptomic analysis with Yesso scallop
(Patinopecten yessoensis). PLoS ONE 2013, 8, e63927. [CrossRef] [PubMed]
37. Ellis, J.R.; Burke, J.M.; Burke, J. EST-SSRs as a resource for population genetic analyses. Heredity 2007, 99,
125–132. [CrossRef] [PubMed]
Mar. Drugs 2019, 17, 466 14 of 15
38. Schmieder, R.; Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011,
27, 863–864. [CrossRef] [PubMed]
39. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics
2014, 30, 2114–2120. [CrossRef]
40. Kopylova, E.; Noé, L.; Touzet, H. SortMeRNA: Fast and accurate filtering of ribosomal RNAs in
metatranscriptomic data. Bioinformatics 2012, 28, 3211–3217. [CrossRef]
41. Quast, C.; Pruesse, E.; Yilmaz, P.; Gerken, J.; Schweer, T.; Yarza, P.; Peplies, J.; Glöckner, F.O. The SILVA
ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res.
2012, 41, D590–D596. [CrossRef]
42. Grabherr, M.G.; Haas, B.J.; Yassour, M.; Levin, J.Z.; Thompson, D.A.; Amit, I.; Adiconis, X.; Fan, L.;
Raychowdhury, R.; Zeng, Q.; et al. Full-length transcriptome assembly from RNA-Seq data without a
reference genome. Nat. Biotechnol. 2011, 29, 644–652. [CrossRef]
43. Waterhouse, R.M.; Seppey, M.; Simão, F.A.; Manni, M.; Ioannidis, P.; Klioutchnikov, G.; Kriventseva, E.V.;
Zdobnov, E.M. BUSCO applications from quality assessments to gene prediction and phylogenomics.
Mol. Biol. Evol. 2018, 35, 543–548. [CrossRef] [PubMed]
44. Jones, P.; Binns, D.; Chang, H.-Y.; Fraser, M.; Li, W.; McAnulla, C.; McWilliam, H.; Maslen, J.; Mitchell, A.;
Nuka, G.; et al. InterProScan 5: Genome-scale protein function classification. Bioinformatics 2014, 30, 1236–1240.
[CrossRef] [PubMed]
45. Mitchell, A.L.; Attwood, T.K.; Babbitt, P.C.; Blum, M.; Bork, P.; Bridge, A.; Brown, S.D.; Chang, H.-Y.;
El-Gebali, S.; Fraser, M.I.; et al. InterPro in 2019: Improving coverage, classification and access to protein
sequence annotations. Nucleic Acids Res. 2019, 47, D351–D360. [CrossRef] [PubMed]
46. Bateman, A.; Martin, M.J.; O’Donovan, C.; Magrane, M.; Alpi, E.; Antunes, R.; Bely, B.; Bingley, M.; Bonilla, C.;
Britto, R.; et al. UniProt: The universal protein knowledgebase. Nucleic Acids Res. 2017, 45, D158–D169.
[CrossRef]
47. El-Gebali, S.; Mistry, J.; Bateman, A.; Eddy, S.R.; Luciani, A.; Potter, S.C.; Qureshi, M.; Richardson, L.J.;
Salazar, G.A.; Smart, A.; et al. The Pfam protein families database in 2019. Nucleic Acids Res. 2019, 47, D427–D432.
[CrossRef] [PubMed]
48. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol.
1990, 215, 403–410. [CrossRef]
49. Kanehisa, M.; Sato, Y.; Furumichi, M.; Morishima, K.; Tanabe, M. New approach for understanding genome
variations in KEGG. Nucleic Acids Res. 2019, 47, D590–D595. [CrossRef]
50. Ashburner, M.; Ball, C.A.; Blake, J.A.; Botstein, D.; Butler, H.; Cherry, J.M.; Davis, A.P.; Dolinski, K.;
Dwight, S.S.; Eppig, J.T.; et al. Gene Ontology: Tool for the unification of biology. Nat. Genet. 2000, 25, 25–29.
[CrossRef]
51. The R Development Core Team. R: A Language and Environment for Statistical Computing; R Foundation for
Statistical Computing: Vienna, Austria, 2018.
52. Kaas, Q.; Yu, R.; Jin, A.-H.; Dutertre, S.; Craik, D.J. ConoServer: Updated content, knowledge, and discovery
tools in the conopeptide database. Nucleic Acids Res. 2012, 40, D325–D330. [CrossRef]
53. Lavergne, V.; Dutertre, S.; Jin, A.-H.; Lewis, R.J.; Taft, R.J.; Alewood, P.F. Systematic interrogation of the
Conus marmoreus venom duct transcriptome with ConoSorter reveals 158 novel conotoxins and 13 new
gene superfamilies. BMC Genom. 2013, 14, 708. [CrossRef]
54. Koua, D.; Brauer, A.; Laht, S.; Kaplinski, L.; Favreau, P.; Remm, M.; Lisacek, F.; Stöcklin, R. ConoDictor:
A tool for prediction of conopeptide superfamilies. Nucleic Acids Res. 2012, 40, W238–W241. [CrossRef]
[PubMed]
55. Sievers, F.; Wilm, A.; Dineen, D.; Gibson, T.J.; Karplus, K.; Li, W.; Lopez, R.; McWilliam, H.; Remmert, M.;
Söding, J.; et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal
Omega. Mol. Syst. Biol. 2011, 7, 539. [CrossRef] [PubMed]
56. Stamatakis, A. RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies.
Bioinformatics 2014, 30, 1312–1313. [CrossRef] [PubMed]
57. Untergasser, A.; Cutcutache, I.; Koressaar, T.; Ye, J.; Faircloth, B.C.; Remm, M.; Rozen, S.G. Primer3—New
capabilities and interfaces. Nucleic Acids Res. 2012, 40, e115. [CrossRef] [PubMed]
58. Kalinowski, S.T.; Taper, M.L.; Marshall, T.C. Revising how the computer program cervus accommodates
genotyping error increases success in paternity assignment. Mol. Ecol. 2007, 16, 1099–1106. [CrossRef] [PubMed]
Mar. Drugs 2019, 17, 466 15 of 15
59. Rousset, F. genepop’007: A complete re-implementation of the genepop software for Windows and Linux.
Mol. Ecol. Resour. 2008, 8, 103–106. [CrossRef] [PubMed]
60. Rice, W.R. Analyzing Tables of Statistical Tests. Evolution 1989, 43, 223–225. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
